FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Help Industry with Bad Labs: Post

A Hyman, Phelps & McNamara medical device regulatory expert and attorney say FDA should help industry learn how to avoid labs that produce fraudulent ...

latest-news-card-1
Medical Devices

QS, MDR Issues Seen in Exactech Inspection

FDA warns Gainesville, FL-based Exactech about Quality System and Medical Device Report violations in its manufacturing of orthopedic implants and acc...

latest-news-card-1
Human Drugs

Minor Drug Labeling Change Reporting Guide

FDA publishes a draft guidance with recommendations for NDA and ANDA applicants for nonprescription drugs to document minor labeling changes.

latest-news-card-1

False or Misleading Senvelgo Claims: CVM

CVM warns Boehringer Ingelheim Animal Health USA that promotional communications for its Senvelgo make false and misleading claims that contradict the...

latest-news-card-1
Medical Devices

Cybersecurity Guidance Updates Proposed

FDA publishes a draft guidance proposing select updates to its existing premarket cybersecurity guidance.

latest-news-card-1
Marketing

Digital Drug Marketing Workshop Themes

A Duke-Margolis Institute for Health Policy report on an FDA-funded virtual workshop on drug digital marketing identifies several cross-cutting themes...

latest-news-card-1
Medical Devices

Most MDRs Hit Device Function Issues: Study

FDA and Instem researchers say 92% of Medical Device Reports filed between 2011 and 2021 involved device issues rather than patient adverse events.

latest-news-card-1
Human Drugs

Adcetris Positive Lymphoma Data: Pfizer

Pfizer plans to share with FDA favorable data from its Phase 3 study of the antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with...

latest-news-card-1
Human Drugs

Lexicon Refiling NDA for Sotagliflozin in Diabetes

Lexicon Pharmaceuticals says that after receiving recent FDA feedback it plans to resubmit its NDA for sotagliflozin oral tablets as an adjunct to ins...

latest-news-card-1
Human Drugs

Acadia Pharmaceuticals Nixes Schizophrenia Drug

Acadia Pharmaceuticals stops developing pimavanserin for treating negative symptoms of schizophrenia based on disappointing top-line results from a Ph...